Post-traumatic Stress Disorder in Spontaneous Abortion

NCT ID: NCT07306676

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this questionnaire-based study is to prospectively assess the prevalence of post-traumatic stress disorder (PTSD) symptoms in a population of women who have experienced a spontaneous miscarriage during the first trimester of pregnancy. The investigation into the prevalence of PTSD symptoms will assist in better identifying women who may benefit from early psychological intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A questionnaire-based study will be conducted with prospective inclusion of participants, based on the analysis of medical documentation and self-administered questionnaires. The following questionnaires are proposed for use:

i. Impact of Event Scale - Revised (IES-R) is a 22-item test that measures the level of stress and anxiety resulting from traumatic events. It is utilized as a screening tool in diagnosing post-traumatic stress disorder (PTSD). The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience: 0 - Not at all

1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often

Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:

0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD. The questionnaire will be completed during hospitalization.

ii. Posttraumatic Stress Disorder Checklist - Specific (PCL-S) is a 17-item test designed to detect symptoms of PTSD resulting from a specific traumatic event. This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points: Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points

After totaling the points, they are classified as follows:

17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms. The questionnaire will be completed during a routine follow-up visit at the outpatient clinic eight weeks post-discharge from the hospital.

iii. Trauma Recovery Measure (TRM) is a 15-item tool designed to assess trauma and the recovery process. It enables a structured evaluation of the multifaceted impact of trauma on an individual, facilitating the adjustment of support and intervention strategies.

The TRM provides a total score as well as three subscale scores that assess the cognitive aspects of the individual following the experience of traumatic events. The three subscales within the TRM include:

* Validation: This subscale measures the acceptance and self-acceptance of the trauma survivor as they are, despite the traumatic experience, and evaluates the development of internal worth and dignity.
* Liberation: This subscale assesses the survivor's ability to free themselves from control, entrapment, and/or oppression caused by the trauma, and their capacity to live in a way that allows them to feel empowered and confident in making positive decisions for themselves and others.
* Positive Self: This subscale measures the presence of positive cognitive aspects that generate feelings of care, compassion, and/or kindness.

The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:

* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).

The questionnaire will be completed during a routine follow-up visit at the outpatient clinic eight weeks post-discharge from the hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spontaneous Abortion

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Spontaneous Abortion PTSD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women who experienced a spontaneous miscarriage during the first trimester of pregnancy

Recruitment will take place at the Department of Endocrinology and Gynecology at the University Hospital in Kraków, located at ul. Kopernika 23, 31-501 Kraków, and at the Department of Gynecology and Gynecological Oncology NSSU, located at Jakubowskiego 2, 30-688 Kraków. The study plans to enroll 200 women aged 18 to 45 years who have been hospitalized due to a spontaneous miscarriage.

Impact of Event Scale - Revised (IES-R) questionnaire

Intervention Type DIAGNOSTIC_TEST

The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience:

0 - Not at all

1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often

Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:

0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD.

Posttraumatic Stress Disorder Checklist - Specific (PCL-S) questionnaire

Intervention Type DIAGNOSTIC_TEST

This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points:

Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points

After totaling the points, they are classified as follows:

17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms.

Trauma Recovery Measure (TRM) questionnaire

Intervention Type DIAGNOSTIC_TEST

The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:

* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Impact of Event Scale - Revised (IES-R) questionnaire

The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience:

0 - Not at all

1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often

Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:

0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD.

Intervention Type DIAGNOSTIC_TEST

Posttraumatic Stress Disorder Checklist - Specific (PCL-S) questionnaire

This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points:

Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points

After totaling the points, they are classified as follows:

17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms.

Intervention Type DIAGNOSTIC_TEST

Trauma Recovery Measure (TRM) questionnaire

The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:

* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* spontaneous abortion
* gestational age up to 14 weeks.

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jagiellonian University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Iwona Magdalena Gawron

PhD, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iwona Gawron, PhD, MD

Role: STUDY_DIRECTOR

Jagiellonian University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jagiellonian University Medical College, Department of Gynecology and Obstetrics

Krakow, Malopolska, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Iwona Gawron, PhD, MD

Role: CONTACT

Phone: +48 12424870

Email: [email protected]

Robert Jach, Prof., PhD

Role: CONTACT

Phone: +48 12424871

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Iwona M Gawron, MD, PhD

Role: primary

Robert Jach, Prof., PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

118.0043.1.343.2025

Identifier Type: -

Identifier Source: org_study_id